Cancer affects more than just the body. Patients and survivors oftentimes face complex emotions or feelings of sadness, depression, or anxiety. The Psychosocial Oncology Program at Dana Farber Cancer Institute works to define patients and survivors concerns and develop individual treatment plans aimed at helping them cope with emotional stress through all phases of the cancer experience.



Dr. John Raymond Peteet, a member of the Dana-Farber Psychosocial Oncology Center, will be the guest speaker. Dr. Peteet works extensively with prostate cancer patients and survivors.



Wednesday's webcast will also feature an update on the PSA Test Issue, concerning the recent USPSTF Recommendation. Visit PHEN?s homepage for relevant links related to the PSA Test Issue.



Mr. Mark Kennedy, PHEN Clinical Trials Educator, will provide an update on the success of the MDV3100 AFFIRM Phase 3 Clinical Trial, and present information on the MDV3100 PREVAIL trial.



Send in questions during the webcast, to rapcancer@prostatehealthed.org.